REBEKAH ALDRIDGE: Open Payments
NPI 1427386770 · GRANTSVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 21 payments from 13 companies in 2025. Trend: 2023 $37 · 2024 $120 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $107 |
| Novo Nordisk Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 1 | $34 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: Wegovy, CAPLYTA, QULIPTA, Qelbree, VRAYLAR, NURTEC ODT, MOUNJARO, Cologuard Collection Kit.
Industry payments across UT — which companies pay providers there.
